vs

Side-by-side financial comparison of Amarin Corp plc (AMRN) and R F INDUSTRIES LTD (RFIL). Click either name above to swap in a different company.

Amarin Corp plc is the larger business by last-quarter revenue ($45.1M vs $22.7M, roughly 2.0× R F INDUSTRIES LTD). R F INDUSTRIES LTD runs the higher net margin — 0.8% vs -23.3%, a 24.0% gap on every dollar of revenue. On growth, R F INDUSTRIES LTD posted the faster year-over-year revenue change (22.9% vs 7.0%). Over the past eight quarters, R F INDUSTRIES LTD's revenue compounded faster (29.8% CAGR vs -18.3%).

Amarin Corporation is an Irish-American biopharmaceutical company founded in 1993 and headquartered in Dublin, Ireland and Bridgewater, New Jersey. The company develops and markets medicines for the treatment of cardiovascular disease. It has developed the drug Vascepa (AMR-101), a prescription grade omega-3 fatty acid.

Tootsie Roll Industries is an American manufacturer of confectionery based in Chicago, Illinois. Its best-known products include the namesake Tootsie Rolls and Tootsie Pops. Tootsie Roll Industries currently markets its brands internationally in Canada, Mexico, and over 75 other countries.

AMRN vs RFIL — Head-to-Head

Bigger by revenue
AMRN
AMRN
2.0× larger
AMRN
$45.1M
$22.7M
RFIL
Growing faster (revenue YoY)
RFIL
RFIL
+15.9% gap
RFIL
22.9%
7.0%
AMRN
Higher net margin
RFIL
RFIL
24.0% more per $
RFIL
0.8%
-23.3%
AMRN
Faster 2-yr revenue CAGR
RFIL
RFIL
Annualised
RFIL
29.8%
-18.3%
AMRN

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
AMRN
AMRN
RFIL
RFIL
Revenue
$45.1M
$22.7M
Net Profit
$-10.5M
$173.0K
Gross Margin
36.8%
Operating Margin
35.5%
4.0%
Net Margin
-23.3%
0.8%
Revenue YoY
7.0%
22.9%
Net Profit YoY
33.0%
172.7%
EPS (diluted)
$0.01

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AMRN
AMRN
RFIL
RFIL
Q1 26
$45.1M
Q4 25
$49.2M
$22.7M
Q3 25
$49.7M
$19.8M
Q2 25
$72.7M
$18.9M
Q1 25
$42.0M
$19.2M
Q4 24
$62.3M
$18.5M
Q3 24
$42.3M
$16.8M
Q2 24
$67.5M
$16.1M
Net Profit
AMRN
AMRN
RFIL
RFIL
Q1 26
$-10.5M
Q4 25
$-1.2M
$173.0K
Q3 25
$-7.7M
$392.0K
Q2 25
$-14.1M
$-245.0K
Q1 25
$-15.7M
$-245.0K
Q4 24
$-48.6M
$-238.0K
Q3 24
$-25.1M
$-705.0K
Q2 24
$1.5M
$-4.3M
Gross Margin
AMRN
AMRN
RFIL
RFIL
Q1 26
Q4 25
47.1%
36.8%
Q3 25
44.7%
34.0%
Q2 25
69.2%
31.5%
Q1 25
59.8%
29.8%
Q4 24
-15.4%
31.3%
Q3 24
38.5%
29.5%
Q2 24
63.4%
29.9%
Operating Margin
AMRN
AMRN
RFIL
RFIL
Q1 26
35.5%
Q4 25
-12.9%
4.0%
Q3 25
-22.4%
3.6%
Q2 25
-22.0%
0.6%
Q1 25
-39.9%
0.3%
Q4 24
-84.3%
0.5%
Q3 24
-59.5%
-2.5%
Q2 24
-0.8%
-2.6%
Net Margin
AMRN
AMRN
RFIL
RFIL
Q1 26
-23.3%
Q4 25
-2.5%
0.8%
Q3 25
-15.6%
2.0%
Q2 25
-19.4%
-1.3%
Q1 25
-37.4%
-1.3%
Q4 24
-78.0%
-1.3%
Q3 24
-59.4%
-4.2%
Q2 24
2.3%
-26.7%
EPS (diluted)
AMRN
AMRN
RFIL
RFIL
Q1 26
Q4 25
$0.00
$0.01
Q3 25
$-0.02
$0.04
Q2 25
$-0.03
$-0.02
Q1 25
$-0.04
$-0.02
Q4 24
$-0.12
$-0.02
Q3 24
$-0.06
$-0.07
Q2 24
$0.00
$-0.41

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AMRN
AMRN
RFIL
RFIL
Cash + ST InvestmentsLiquidity on hand
$307.8M
$5.1M
Total DebtLower is stronger
Stockholders' EquityBook value
$35.2M
Total Assets
$645.8M
$73.0M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AMRN
AMRN
RFIL
RFIL
Q1 26
$307.8M
Q4 25
$302.6M
$5.1M
Q3 25
$286.6M
$3.0M
Q2 25
$298.7M
$3.6M
Q1 25
$281.8M
$1.3M
Q4 24
$294.2M
$839.0K
Q3 24
$305.7M
$1.8M
Q2 24
$306.7M
$1.4M
Stockholders' Equity
AMRN
AMRN
RFIL
RFIL
Q1 26
Q4 25
$459.3M
$35.2M
Q3 25
$458.9M
$34.8M
Q2 25
$464.9M
$34.2M
Q1 25
$473.7M
$34.2M
Q4 24
$486.2M
$34.1M
Q3 24
$531.4M
$34.1M
Q2 24
$551.9M
$34.6M
Total Assets
AMRN
AMRN
RFIL
RFIL
Q1 26
$645.8M
Q4 25
$670.8M
$73.0M
Q3 25
$659.8M
$73.2M
Q2 25
$670.1M
$72.7M
Q1 25
$655.7M
$70.4M
Q4 24
$685.3M
$71.0M
Q3 24
$750.6M
$71.9M
Q2 24
$799.9M
$72.8M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AMRN
AMRN
RFIL
RFIL
Operating Cash FlowLast quarter
$2.1M
Free Cash FlowOCF − Capex
$2.0M
FCF MarginFCF / Revenue
9.0%
Capex IntensityCapex / Revenue
0.3%
Cash ConversionOCF / Net Profit
12.13×
TTM Free Cash FlowTrailing 4 quarters
$4.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AMRN
AMRN
RFIL
RFIL
Q1 26
Q4 25
$15.3M
$2.1M
Q3 25
$-12.7M
$-311.0K
Q2 25
$16.6M
$2.2M
Q1 25
$-12.5M
$601.0K
Q4 24
$-13.3M
$-244.0K
Q3 24
$-2.4M
$2.4M
Q2 24
$-2.7M
$197.0K
Free Cash Flow
AMRN
AMRN
RFIL
RFIL
Q1 26
Q4 25
$2.0M
Q3 25
$-419.0K
Q2 25
$2.2M
Q1 25
$574.0K
Q4 24
$-418.0K
Q3 24
$2.1M
Q2 24
$28.0K
FCF Margin
AMRN
AMRN
RFIL
RFIL
Q1 26
Q4 25
9.0%
Q3 25
-2.1%
Q2 25
11.4%
Q1 25
3.0%
Q4 24
-2.3%
Q3 24
12.6%
Q2 24
0.2%
Capex Intensity
AMRN
AMRN
RFIL
RFIL
Q1 26
Q4 25
0.3%
Q3 25
0.5%
Q2 25
0.2%
Q1 25
0.1%
Q4 24
0.9%
Q3 24
1.5%
Q2 24
1.0%
Cash Conversion
AMRN
AMRN
RFIL
RFIL
Q1 26
Q4 25
12.13×
Q3 25
-0.79×
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
-1.81×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

AMRN
AMRN

U.S$35.6M79%
Europe$4.9M11%
Rest-of-World (ROW)$2.8M6%
Licensing & Royalties$1.8M4%

RFIL
RFIL

US$20.9M92%
Non Us$1.8M8%

Related Comparisons